Detection of Graft Versus Host Disease With [18F]F-AraG
Clinical trial NCT03367962 · COMPLETED
Trial details
- NCT number
- NCT03367962
- Sponsor
- CellSight Technologies, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-15
- Primary completion
- 2023-06-21
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.